| |
| |
|
| Insider
Information: |
Duggan Robert W |
| Relationship: |
Chief Executive Office... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
594,894,754 |
|
|
Indirect Shares
|
1,046,059 |
|
|
| Direct
Value |
$4,722,549,774 |
|
|
|
Indirect Value
|
$10,449,250 |
|
|
| Total
Shares |
595,940,813 |
|
|
| Total
Value |
$4,732,999,024 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
19
|
0
|
|
Stock
price went up :
|
17
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
8.5
|
0.0
|
| Percentage
Gain/Loss : |
 51.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Intuitive Surgical Inc |
ISRG |
Director |
2011-05-18 |
1,000 |
2011-02-09 |
0 |
Premium* |
|
|
Pharmacyclics Inc |
PCYC |
Chairman and CEO, Dire... |
2015-05-26 |
0 |
2015-05-26 |
0 |
Premium* |
|
|
Pulse Biosciences, Inc. |
PLSE |
Director, 10% Owner |
2023-12-12 |
36,984,179 |
2023-12-12 |
843,634 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2019-03-20 |
5,555,414 |
2019-03-20 |
202,425 |
Premium* |
|
|
Summit Therapeutics Inc |
SMMT |
Chief Executive Office... |
2023-03-06 |
552,354,161 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
318 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 13
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-11-08 |
4 |
B |
$4.75 |
$71,250 |
I/I |
15,000 |
446,982 |
1.5 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-11-08 |
4 |
B |
$4.75 |
$1,854,000 |
D/D |
390,000 |
2,862,956 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2006-12-29 |
4 |
B |
$4.85 |
$155,560 |
D/D |
31,661 |
2,894,617 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-01-03 |
4 |
B |
$4.85 |
$529,276 |
D/D |
108,339 |
3,002,956 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-02-21 |
4 |
B |
$2.58 |
$1,831,467 |
D/D |
654,619 |
3,657,575 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-02-21 |
4 |
B |
$2.80 |
$172,800 |
I/I |
60,000 |
506,982 |
1.5 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-02-21 |
4 |
B |
$2.98 |
$775,491 |
D/D |
250,381 |
3,907,956 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-08-14 |
4 |
B |
$2.17 |
$47,949 |
I/I |
22,000 |
528,982 |
1.5 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-09-05 |
4 |
B |
$2.57 |
$20,155 |
I/I |
7,778 |
536,760 |
1.5 |
- |
|
| PCYC |
Pharmacyclics Inc |
10% Owner |
– – • |
2007-09-07 |
4 |
B |
$2.50 |
$52,626 |
D/D |
20,433 |
3,928,389 |
2.45 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-05-30 |
4 |
B |
$1.05 |
$2,081,815 |
I/I |
1,982,681 |
1,982,681 |
2.25 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-05-30 |
4/A |
B |
$1.05 |
$2,005,160 |
I/I |
1,909,676 |
1,909,676 |
2.25 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-23 |
4 |
B |
$1.70 |
$139,431 |
D/D |
82,018 |
4,776,857 |
3.92 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-24 |
4 |
B |
$1.87 |
$71,060 |
D/D |
38,000 |
4,814,857 |
3.92 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-25 |
4 |
B |
$1.74 |
$174 |
D/D |
100 |
4,814,957 |
3.84 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-06-26 |
4 |
B |
$1.71 |
$27,873 |
D/D |
16,300 |
4,831,257 |
3.92 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-08-21 |
4 |
B |
$1.60 |
$265,667 |
D/D |
166,042 |
4,997,299 |
3.92 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-08-22 |
4 |
B |
$1.60 |
$1,920 |
D/D |
1,200 |
4,998,499 |
3.84 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-09-05 |
4 |
B |
$2.47 |
$187,881 |
D/D |
76,065 |
5,074,564 |
3.92 |
- |
|
| PCYC |
Pharmacyclics Inc |
Director |
– • • |
2008-09-05 |
4 |
B |
$2.47 |
$247,000 |
I/I |
100,000 |
515,760 |
2.25 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman and CEO |
• • • |
2010-06-21 |
4 |
B |
$6.51 |
$6,999,995 |
D/D |
1,075,268 |
10,904,702 |
3.23 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chairman & CEO |
• • • |
2011-06-21 |
4 |
B |
$8.85 |
$6,000,300 |
D/D |
678,000 |
12,081,244 |
3.23 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-02-09 |
4 |
B |
$11.64 |
$484,503 |
D/D |
41,624 |
2,173,359 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-03-16 |
4 |
B |
$22.54 |
$1,782,352 |
D/D |
73,782 |
2,247,141 |
2.45 |
- |
|
| PLSE |
Pulse Biosciences, Inc. |
10% Owner |
– – • |
2017-03-17 |
4 |
B |
$24.07 |
$622,452 |
D/D |
25,859 |
2,273,000 |
2.45 |
- |
|
318 Records found
|
|
Page 2 of 13 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
